Akagera Medicines Africa

Akagera Medicines is a biotechnology company dedicated to developing and manufacturing vaccines and therapeutics for infectious diseases, with a primary focus on tuberculosis and HIV. The company utilizes a proprietary lipid nanoparticle (LNP) delivery system to create mRNA-based medicines tailored for the African context. Headquartered in Kigali, Rwanda, with a research presence in Boston, Akagera operates through a unique public-private partnership, with the Rwanda Social Security Board (RSSB) as its majority shareholder. Its mission is to build a sustainable biotech ecosystem in Africa by integrating world-class R&D with local manufacturing capabilities. The company is currently advancing its lead programs through pre-clinical development with the goal of initiating clinical trials in Africa.